Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Retinoid Receptor

Retinoid receptors are nuclear receptors (a class of proteins) that bind to retinoids. When bound to a retinoid, they act as transcription factors, altering the expression of genes with corresponding response elements. Significant age-related declines in the levels of retinoid receptors in the forebrains of rats have been reversed by supplementation with the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which can restore neurogenesis. Subtypes include: Retinoic acid receptors (RARs), Retinoid X receptors (RXRs), RAR-related orphan receptors (RORs).

ER 50891
T22767187400-85-7In house
ER-50891 is a potent retinoic acid receptor alpha (RARα) antagonist. er-50891 reduces the inhibitory effect of allosteric retinoic acid and restores osteoblast differentiation induced by bone morphogenetic protein 2.
  • $163
In Stock
Size
QTY
BMS 195614
T22192253310-42-8
BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
  • $181
In Stock
Size
QTY
Adapalene
T1093106685-40-9
Adapalene (CD271) is a dual RAR and RXR agonist, utilized in the treatment of skin conditions.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
LY2955303
T158111433497-19-8
LY2955303 is an effective and selective antagonist of retinoic acid receptor gamma (RARγ, Ki = 1.09 nM).
  • $35
In Stock
Size
QTY
LE135
T22920155877-83-1
LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), showing higher affinity for RARβ. It is highly selective over RARγ, RXRα, RXRβ, and RXRγ. LE135 also acts as a potent TRPV1 and TRPA1 receptor activator with EC50s of 2.5 μM and 20 μM, respectively.
  • $39
In Stock
Size
QTY
HX 531
T22843188844-34-0
HX 531 is a RXR antagonist (IC50 of 18 nM). HX 531 prevents HF diet-induced obesity, insulin resistance, and diabetes by reducing tissue TG content in white adipose tissue (WAT), skeletal muscle, and liver in mice.
  • $39
In Stock
Size
QTY
Talarozole
T7370201410-53-9
Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA) that inhibits CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively, for treating acne, psoriasis, and other keratinization disorders.
  • $66
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MM 11253
T23005345952-44-5
MM 11253 is a RARγ antagonist with IC50 of 44nM.
  • $34
In Stock
Size
QTY
Bigelovin
TN67353668-14-2
Bigelovin is a selective retinoid X receptor α agonist. Bigelovin suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation.It is also known as a potent cytotoxic sesquiterpene lactone from Inula sp.
  • $93
In Stock
Size
QTY
palovarotene
T4538410528-02-8
Palovarotene (Ro 3300074) is an agonist of nuclear retinoic acid receptor γ (RAR-γ).
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Bexarotene
T6410153559-49-0
Bexarotene (LGD1069) is a retinoid analogue that is used to treat the skin manifestations of cutaneous T cell lymphoma (CTCL).
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Fluorobexarotene
T113031190848-23-7In house
Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene. Fluorobexarotene  is a potent retinoid-X-receptor (RXR) agonist, with a Ki value of 12 nM and an EC50 value of 43 nM for RXRα receptor. Fluorobexarotene possesses an apparent RXR binding affinity that is 75% greater than Bexarotene.
  • $183
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AM580
T5854102121-60-8
AM580 (CD336) is a retinoic acid receptor agonist that is selective for RARα( IC50 : 8 nM )
  • $33
In Stock
Size
QTY
TTNPB
T128871441-28-6
TTNPB (Ro 13-7410,AGN-191183), a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.
  • $33
In Stock
Size
QTY
AR7
T395580306-38-3
AR7 is a retinoic acid receptor α (RARα) antagonist.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
Fenretinide
T187265646-68-6
Fenretinide (4-HPR) is an orally-active synthetic retinoid derivative with potential antineoplastic and chemopreventive activities.
  • $34
In Stock
Size
QTY
AGN 193109
TQ0097171746-21-7
AGN 193109, a retinoid analog, is a potent and specific antagonist of RARs (Kds: 2 nM, 2 nM, and 3 nM for RARα, RARβ, and RARγ).
  • $62
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CD437
T4371125316-60-1
CD437 (AHPN) is a specifc Retinoic Acid Receptor γ (RARγ) agonist.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CD2665
T14911170355-78-9
CD2665 is an orally active antagonist of retinoic acid receptor (RAR). For RARγ and RARβ, the Kis are 110 nM and 306 nM.
  • $83
In Stock
Size
QTY
Isotretinoin
T16114759-48-2
Isotretinoin (13-cis-Retinoic acid) binds to and activates nuclear retinoic acid receptors (RARs), which act as transcription factors that promote cell differentiation and apoptosis. This naturally occurring retinoic acid has potential antineoplastic activity, exhibits immunomodulatory and anti-inflammatory responses, and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.
  • $36
In Stock
Size
QTY
TargetMol | Citations Cited
Liarozole
T11847L115575-11-6
Liarozole (R75251 dihydrochloride) is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).Liarozole dihydrochloride is an imidazole derivative; it is being investigated as a non-hormonal agent in prostate cancer and in the treatment of various other cancers and skin disorders.
  • $76
In Stock
Size
QTY
TargetMol | Inhibitor Sale
UVI 3003
T17209847239-17-2
UVI 3003 is a highly selective antagonist of the retinoid X receptor, inhibiting Xenopus and human RXRα in Cos7 cells with IC50 values of 0.22 μM and 0.24 μM, respectively.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Tamibarotene
T669494497-51-5
Tamibarotene (Amnolake) is an orally active, synthetic retinoid, developed to overcome all-trans retinoic acid (ATRA) resistance, with potential antineoplastic activity.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
CD3254
T14912196961-43-0
CD3254 is a selective and potent retinoid X receptor-like (RXR) agonist that inhibits neuronal cell death with OGD/reoxygenation.
  • $50
In Stock
Size
QTY
Ch55
T14946110368-33-7
Ch55 (3,5-Di-tert-butylchalcone) is an effective inducer of the differentiation of HL60 cells (EC50 = 200 nM) and shows high affinity with RAR-α and RAR-β receptors. Ch55 can be used in studies about cancer.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Peretinoin
TQ006481485-25-8
Peretinoin (NIK333) is an oral acyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors such as RXR and RAR.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ro 41-5253
T28589144092-31-9
Ro 41-5253 is an orally active RARα antagonist, ligand, and partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ. It exhibits antitumor activity, inhibits proliferation, and induces apoptosis in MCF-7 and ZR-75.1 estrogen receptor-positive breast cancer cells.
  • $52
In Stock
Size
QTY
Tazarotene
T6696118292-40-3
Tazarotene (Zorac) is a synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation.
  • $32
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Acitretin
T133055079-83-9
Acitretin (Ro 10-1670) is a second-generation systemic retinoid used in the treatment of psoriasis.
  • $111
In Stock
Size
QTY
TargetMol | Citations Cited
WYC-209
T53412131803-90-0
WYC-209 inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs, IC50: 0.19 uM). It targets the retinoic acid receptor (RAR).
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-8012
T242401346513-17-4In house
K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AC-261066
T14089870773-76-5
AC-261066 is an orally available and isoform-selective agonist of RARβ2 with a pEC50 of 8.0.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
trifarotene
T7586895542-09-3
Trifarotene (CD5789) is a potent and selective RARγ agonist, exhibiting 65-fold and 16-fold selectivity for RARγ (EC50=7.7 nM) over RARα (EC50=500 nM) and RARβ (EC50=125 nM).
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PA452
T16425457657-34-0
PA452 is a selective antagonist of retinoic X receptor (RXR) and suppresses the effect of Retinoic acid on Th1 Th2 development.
  • $84
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Tarenflurbil
T584351543-40-9
Tarenflurbil ((R)-Flurbiprofen) is the non-cyclooxygenase inhibiting R-enantiomer of the NSAID flurbiprofen, evaluated as a treatment for Alzheimer's disease.
  • $50
In Stock
Size
QTY
LG-100064
T11844153559-46-7
LG-100064 is an agonist of retinoid-X-receptor (RXR)(EC50s of 330 nM, 200 nM, and 260 nM for RXRα, RXRβ and RXRγ)
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Etodolac
T100241340-25-4
Etodolac (AY-24236) inhibits the activity of cyclooxygenase I and II, thereby preventing the formation of prostaglandin which is involved in the induction of pain, fever, and inflammation. Etodolac is a pyranocarboxylic acid and non-steroidal anti-inflammatory drug (NSAID) with antipyretic and analgesic activities. It also inhibits platelet aggregation by blocking platelet cyclooxygenase and the subsequent formation of thromboxane A2.
  • $34
In Stock
Size
QTY
Oxybenzone
T0499131-57-7
Oxybenzone is a UV filter commonly used in tanning and skin protection agents. It is a derivative of benzophenone and is used as an endocrine disrupting chemical that penetrates the placental and blood-brain barriers. It impairs autophagy, alters epigenetic status and disrupts vitamin X-like receptor signaling in apoptotic neuronal cells.
  • $40
In Stock
Size
QTY
Mofarotene
T68104125533-88-2In house
Mofarotene (Ro-40-8757) is a small molecule compound that shows considerable antitumor activity in many cancer cell lines and can be used for the treatment of tumors and respiratory diseases.Mofarotene is a retinoic acid analog that binds to and activates retinoic acid receptors (RARs), which alters the expression of certain genes, leading to reduced cell differentiation and cell proliferation in susceptible cells.
  • $109
In Stock
Size
QTY
AGN 196996
T10261958295-17-5
AGN 196996 is a potent and selective inhibitor of RARα (Ki: 2 nM), exhibiting very low affinity for RARβ (Ki: 1087 nM) and RARγ (Ki: 8523 nM).
  • $90
In Stock
Size
QTY
BMS641
T26854369364-50-1
BMS641 (BMS-209641) is a selective and potent RARβ agonist with high affinity for RARβ, which synergistically activates RARβ and RARgamma to induce cellular maturation into specialized neuronal subtypes.
  • $159
In Stock
Size
QTY
KCL-286
T785751952276-71-9In house
KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI).
  • $81
In Stock
Size
QTY
MSU-42011
T774992456434-36-7In house
MSU-42011 is an orally active retinoid X receptor-like (RXR) agonist. It potently inhibits the expression of iNOS, low SREBP-induced and activated RXR, and p-ERK at the protein level. MSU-42011 has demonstrated antitumor activity in a [kras]-driven mouse model of lung cancer and is effective for the treatment of preclinical [kras]-driven lung cancer with immunomodulatory activity.
  • $41
In Stock
Size
QTY
AC-55649
T1409059662-49-6
AC-55649 is a potent and highly isoform-selective agonist of the human RARβ2 receptor, characterized by a pEC50 of 6.9.
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BMS 753
T22049215307-86-1
BMS 753 is an agonist of isotype-selective retinoic acid receptor α (RARα, Ki= 2 nM).
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BMS453
T21714166977-43-1
BMS453 (BMS-189453), a synthetic retinoid, is a potent and selective agonist of RARβ and a potent testicular toxin. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ.
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AGN 192870
T61588166977-57-7
AGN 192870 is a potent retinoic acid receptor (RAR) antagonist.AGN 192870 can be used to study cell growth arrest, differentiation and apoptosis.
  • $156
In Stock
Size
QTY
Luffariellolide
T21893111149-87-2
Luffariellolide is a terpene compound obtained from the marine sponge Hyrtios communis. It is an inhibitor of human synoviocyte protein phospholipase A2 (HSF-PLA2) and a retinoic acid receptor (RAR) agonist. Luffariellolide inhibits hypoxia (1% O2)-induced HIF-1 activation and inhibits cell growth.
  • $465
35 days
Size
QTY